Omeprazole (API)
Proton pump inhibitor API aligned to global pharmacopoeial monographs. Suitable for delayed release pellets, tablets, and suspensions targeting acid suppression therapies.
Product overview
Omeprazole API from Rraynex is manufactured under WHO-GMP governance with process controls that protect the acid-sensitive benzimidazole structure. High-purity raw materials pass stringent incoming inspection before conversion through controlled synthesis, crystallization, and micronization stages. Inline monitoring tracks pH, particle size, and moisture to keep each batch aligned with IP, BP, USP, and EP specifications. Impurity profiles remain low, supporting downstream formulation into pellets, tablets, or suspensions. We deliver complete technical documentation, including DMF/ASMF summaries, stability data across climatic zones, and validated analytical methods. Packaging is available in nitrogen-flushed fiber drums or smaller lined containers for development work, each qualified for extended transport. Technical teams support method transfer, impurity investigations, and lifecycle change-control. With responsive customer service and global regulatory experience, Rraynex keeps omeprazole API supply secure for partners scaling proton pump inhibitor portfolios.
Technical & formulation advantages
- Controlled pelletization and coating for reproducible dissolution and downstream handling.
- Uniform particle size and morphology suitable for capsule filling and multiparticulate systems.
- Manufactured under WHO-GMP with in-process controls on assay, moisture and related substances.
- Technical support for formulation development, scale-up and regulatory documentation.
Technical specifications are available upon request.
Applications
- Capsule filling and multiparticulate dosage forms (including MUPS where applicable).
- Pharmaceutical formulation and commercial manufacturing for Anti-Ulcerant therapies.
- CDMO and contract manufacturing programs requiring bulk omeprazole (api).
Bulk pharmaceutical supply & commercial manufacture
Rraynex operates as a pharmaceutical pellets manufacturer and supplier based in India, supporting bulk supply, export and contract manufacturing for Omeprazole (API). Supply is available in standard 25/50 kg packaging with batch traceability. Export documentation, DMF/COA access procedures and stability information are provided on request for applicable products.
Contact Rraynex for bulk pellet supply • View manufacturing capabilities
Bulk pharmaceutical supply & product enquiries
Looking to source Omeprazole (API) in bulk? Rraynex supports pharmaceutical companies seeking Omeprazole (API) for formulation development, capsule filling and commercial pharmaceutical manufacturing. Buyers can request product specifications, available strengths, technical documentation, samples where applicable, commercial quotations and bulk supply information.
- product specifications
- available strengths
- technical documentation
- samples where applicable
- commercial quotations
- bulk supply information
B2B supply only — not a consumer pharmacy. Pricing available on request for bulk quantities.
Related capabilities
Related products
Technical specifications
- Grade
- IP / BP / USP / EP
- Type
- API
- Category
- Anti-Ulcerant
- Pack size
- 25/50 kg
- Available strengths
- Custom / On request — Technical specifications are available upon request.
- Certifications
- WHO-GMP, ISO 9001, ISO 14001
Only use specification terms supported by existing product data. Additional technical documentation is available upon request.